Janka Eszter Anna

1.

Szász, I., Koroknai, V., Várvölgyi, T., Pál, L., Szűcs, S., Pikó, P., Emri, G., Janka, E. A., Szabó, I. L., Ádány, R., Balázs, M.: Association of Plasma Lipid Patterns and LDL Cholesterol Levels with Breslow Thickness and Ulceration in Melanoma Patients.
Int. J. Mol. Sci. 26 (4), 1-11, (article identifier: 1716), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2.

Kapitány, A., Soltész, L., Stercel, V., Szabó, L., Somogyi, O., Janka, E. A., Nagy, V., Póliska, S., Gáspár, K., Hendrik, Z., Töröcsik, D., Dajnoki, Z., Szegedi, A.: Chronological maturation of the skin immune barrier is topographically different.
Mucosal Immunol. 18 (3), 730-741, 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

D1 Immunology and Allergy

3.

Janka, E. A., Toka-Farkas, T., Ványai, B., Szabó, I. L., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Development of a Predictive Nomogram Model for Metastatic Progression in Malignant Melanoma.
Bőrgyógyász. venerol. szle. 101 (6), 293, 2025.

DEA

4.

Janka, E. A., Szabó, I. L., Toka-Farkas, T., Soltész, L., Szentkereszty-Kovács, Z., Ványai, B., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Development of Nomograms to Predict the Probability of Recurrence at Specific Sites in Patients with Cutaneous Melanoma.
Cancers. 17 (18), 1-21, (article identifier: 3080), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

5.

Akel, R., Kacsir, I., Kerekes, É., Freytag, C., Szoták, E., Boros-Pál, D., Janka, E. A., Bényei, A., Kardos, G., Bokor, É., Somsák, L., Bai, P., Sipos, A., Kun, S.: Platinum-group metal half-sandwich complexes of sugar-isoxazol(in)e conjugates - synthesis and evaluation of their antineoplastic and antimicrobial activities.
Eur. J. Pharm. Sci. 215, 1-18, (article identifier: 107260), 2025.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

6.

Akel, R., Zaki, A. I., Kerekes, É., Kacsir, I., Kiss, G. A., Freytag, C., Szoták, E., Boros-Pál, D., Janka, E. A., Kardos, G., Bai, P., Somsák, L., Kun, S., Sipos, A., Bokor, É.: Platinum-group metal half-sandwich complexes with C-glucopyranosyl 1,2,3-triazoles and isoxazoles as ligands: synthesis and evaluation as antineoplastic and antimicrobial agents.
Eur. J. Pharm. Sci. 215, 1-20, (article identifier: 107259), 2025.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

7.

Zaki, A. I., Sipos, A., Kacsir, I., Kovács, N. I., Kerekes, É., Szoták, E., Freytag, C., Demény, M. Á., Révész, I., Buglyó, P., Bényei, A., Janka, E. A., Kardos, G., Somsák, L., Bai, P., Bokor, É.: Platinum-group metal-sandwich complexes of 1-(alpa-D-glucopyranosyl)-4-hetaryl-1,2,3-triazoles: synthesis, solution equilibrium studies and investigation of their anticancer and antimicrobial activities.
Front. Chem. 13, 1-23, (article identifier: 1619991), 2025.

doi DEA

Journal metrics:

Q2 Chemistry (miscellaneous)

8.

Szeőcs, D., Vida, B., Petővári, G., Póliska, S., Janka, E. A., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z. T., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling.
GeroScience. 46 (4), 3581-3597, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Aging

Q1 Cardiology and Cardiovascular Medicine

D1 Complementary and Alternative Medicine

Q1 Geriatrics and Gerontology

D1 Veterinary (miscellaneous)

9.

Várvölgyi, T., Janka, E. A., Szász, I., Koroknai, V., Toka-Farkas, T., Szabó, I. L., Ványai, B., Szegedi, A., Emri, G., Balázs, M.: Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
J Clin Med. 13 (1), 1-13, (article identifier: 174), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

10.

Schwarcz, S., Nyerges, P., Bíró, T. I., Janka, E. A., Bai, P., Mikó, E.: Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.
Molecules. 29 (13), 1-16, (article identifier: 3073), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Analytical Chemistry

Q1 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q2 Molecular Medicine

Q1 Organic Chemistry

Q1 Pharmaceutical Science

Q1 Physical and Theoretical Chemistry

11.

Tári, V., Janka, E. A., Emri, G., Nemes, B. Á., Remenyik, É., Gellén, E.: Effect of education on sun-safe behaviour in kidney transplant recipients.
Photodermatol. Photoimmunol. Photomed. 40 (3), 1-8, (article identifier: 12966), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Dermatology

Q3 Immunology

Q3 Immunology and Allergy

Q2 Medicine (miscellaneous)

Q2 Radiology, Nuclear Medicine and Imaging

12.

Szász, I., Koroknai, V., Várvölgyi, T., Pál, L., Szűcs, S., Pikó, P., Emri, G., Janka, E. A., Szabó, I. L., Ádány, R., Balázs, M.: Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.
Int. J. Mol. Sci. 25 (8), 1-15, (article identifier: 4251), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

13.

Janka, E. A., Kollár, S., Szabó, I. L., Toka-Farkas, T., Ványai, B., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Independent prognostic role of clinicopathological characteristics, metastasis site and serum markers in patients with stage IV melanoma treated with.
Bőrgyógyász. venerol. szle. 100 (6), 258, 2024.

DEA

14.

Janka, E. A., Szabó, I. L., Kollár, S., Toka-Farkas, T., Ványai, B., Várvölgyi, T., Kapitány, A., Shabu, H., Szegedi, A., Emri, G.: Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors.
Cancers (Basel). 16, 1-18, (article identifier: 2981), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

15.

Ványai, B., Janka, E. A., Szabó, I. L., Várvölgyi, T., Toka-Farkas, T., Kollár, S., Kapitány, A., Szegedi, A., Emri, G.: Prognosztikus markerek metasztatikus melanomában.
Bőrgyógyász. venerol. szle. 100 (6), 255, 2024.

DEA

16.

Ghani, M., Szabó, B., Alkhatibe, M., Amsalu, H., Zohar, P., Janka, E. A., Mótyán, J. A., Tar, K.: Serine 39 in the GTP-binding domain of Drp1 is involved in shaping mitochondrial morphology.
FEBS Open Bio. 14 (7), 1147-1165, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

17.

Palatka, R., Janka, E. A., Soltész, L., Szabó, I. L., Kapitány, A., Dajnoki, Z., Emri, G., Nagy, G., Palatka, K., Zouboulis, C. C., Szegedi, A., Gáspár, K.: Chronic inflammatory intestinal disorders in hidradenitis suppurativa.
Dermatology. 239 (4), 592-600, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Dermatology

18.

Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E. A., Sipos, A., Hegedűs, C., Uray, K., Nagy, P., Bai, P.: Identification of bacterial metabolites modulating breast cancer cell proliferation and epithelial-mesenchymal transition.
Molecules. 28 (15), 1-18, (article identifier: 5898), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Analytical Chemistry

Q1 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

19.

Jankó, L., Tóth, E., Laczik, M., Rauch, B., Janka, E. A., Bálint, B. L., Bai, P.: PARP2 poly(ADP-ribosyl)ates nuclear factor erythroid 2-related factor 2 (NRF2) affecting NRF2 subcellular localization.
Sci. Rep. 13 (7869), 1-13, (article identifier: 7869), 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

20.

Janka, E. A., Ványai, B., Szabó, I. L., Toka-Farkas, T., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
Front Oncol. 13, 1-11, (article identifier: 1237643), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q2 Oncology

21.

Janka, E. A., Szabó, I. L., Toka-Farkas, T., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors of survival in metastatic melanoma.
Bőrgyógyász. venerol. szle. 96 (6), 435, 2023.

DEA

22.

Antal, D., Janka, E. A., Szabó, J., Szabó, I. L., Szegedi, A., Gáspár, K., Bai, P., Szántó, M.: Culture-based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients.
J. Eur. Acad. Dermatol. Venereol. 36 (9), e731-e733, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Dermatology

Q1 Infectious Diseases

23.

Emri, G., Ványai, B., Soltész, L., Szabó, I. L., Várvölgyi, T., Janka, E. A., Oláh, J.: Melanoma kezelés: merre tovább?.
Bőrgyógyász. venerol. szle. 98 (5), 256-262, 2022.

doi DEA

24.

Molnár, S., Hunya, Z., Gáspár, K., Szerb, I., Szabó, N., Mensch, K., Körösi, É., Bacskai, K., Sántha, Á. K., Janka, E. A., Shadgan, B.: Moderate and Severe Injuries at Five International Olympic-Style Wrestling Tournaments during 2016-2019.
J. Sports Sci. Med. 21, 74-81, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Orthopedics and Sports Medicine

Q1 Physical Therapy, Sports Therapy and Rehabilitation

Q2 Sports Science

25.

Várvölgyi, T., Emri, G., Janka, E. A., Szász, I., Szegedi, A., Balázs, M.: Perifériás vér biomarkerek melanoma malignumban.
Bőrgyógyász. venerol. szle. 98 (4), 165, 2022.

DEA

Janka Eszter Anna

Publication list